Skip to search formSkip to main contentSkip to account menu

micafungin

Known as: micafungin [Chemical/Ingredient] 
A semi-synthetic echinocandin derived from a natural product of the fungus Coleophama empedri with potent antifungal activity. Micafungin, like other… 
National Institutes of Health

Related topics

Related topics

11 relations

Broader (3)

Antifungal AgentsEchinocandinsLipopeptides

Narrower (3)

FK 463MICAFUNGIN SODIUMMycamine
MICAFUNGIN SODIUM 100 MG Injection [Mycamine]Micafungin:MCnc:Pt:Ser/Plas:QnMicafungin:Susc:Pt:Isolate:OrdQnMicafungin:Susc:Pt:Isolate:OrdQn:MIC

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2015
2015
Candida parapsilosis, C. orthopsilosis y C. metapsilosis: epidemiología de las candidemias, patrones de sensibilidad y mecanismos de resistencia a las equinocandinas
In the study presented, a retrospective study was carried out in which the diagnosed candidemias were analysed over a 15-year… 
2011
2011
Endotoxin does not alter the pharmacokinetics of micafungin, but it impairs biliary excretion of micafungin via multidrug resistance-associated protein 2 (ABCC2/Mrp2) in rats
Micafungin, a newly developed echinocandin-type antifungal agent, is widely used for the treatment of deep-seated fungal… 
2010
2010
Micafungin in a nutshell: state of affairs on the pharmacological and clinical aspects of the novel echinocandin
Micafungin is one of three echinocandin antifungals approved by the US FDA and the European Medicines Agency (EMA). Like all… 
Review
2009
Review
2009
Micafungin - the newest echinocandin.
Micafungin is one of three currently FDA-approved echinocandins. It has potent in vitro activity against Candida species… 
2009
2009
Role for Fks 1 in the Intrinsic Echinocandin Resistance of Fusarium solani as Evidenced by Hybrid Expression in Saccharomyces cerevisiae
The opportunistic mold Fusarium solani is intrinsically resistant to cell wall synthesis-inhibiting echinocandins (ECs… 
2005
2005
[Combination therapy of micafungin and itraconazole for a case of pulmonary aspergillosis].
The patient was a 73-year-old female who visited a physician with a chief complaint of fever, and was diagnosed with pneumonia… 
2005
2005
Effect of Antifungal Drugs on Cytochrome P 450 ( CYP ) 1 A 2 , CYP 2 D 6 , and CYP 2 E 1 Activities in Human Liver Microsomes
cafungin, miconazole, and voriconazole, are widely used in the treatment of systemic candidal infections and mycoses. The… 
2005
2005
Effect of Antifungal Drugs on Cytochrome P 450 ( CYP ) 2 C 9 , CYP 2 C 19 , and CYP 3 A 4 Activities in Human Liver Microsomes
zymes that catalyzes the oxidation of a wide variety of xenobiotic chemicals, including drugs and carcinogens. Multiple-drug… 
2004
2004
Evaluation of the Use of Micafungin in the Field of Hematology and Future Issues
We evaluated the usage, effectiveness, and adverse reactions of micafungin (MCFG) in 17 patients with hematological disorders (6… 
Review
2003
Review
2003
Micafungin: A new echinocandin antifungal (PDF)
A new echinocandin, micafungin (Mycamine, Fujisawa), is currently under review for the treatment of systemic mycoses. If approved…